Loading organizations...
§ Private Profile · Tokyo, Tokyo, Japan
Regenerative medicine for heart disease treatment.
Heartseed has raised $76.6M across 3 funding rounds.
Heartseed has raised $76.6M in total across 3 funding rounds.
Heartseed has raised $76.6M across 3 funding rounds. Most recently, it raised $14.3M Series D in May 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 25, 2023 | $14.3M Series D | — | Atsushi Sakano, Arcus South East Asia, Japan Co Invest IV Limited Partnership, Keio Innovation Initiative, Koei Tecmo Capital, Medical Incubator Japan, Nikon SBI Innovation Fund, Private Equity Co Invest II Limited Partnership, SMBC Venture Capital, UTokyo Innovation Platform | Announced |
| Jun 11, 2021 | $36.5M Series C | — | Itochu Chemical Frontier, Keio Innovation Initiative, Medical Incubator Japan, MEDIPAL HOLDINGS CORPORATION, Nissay Capital, SBI Group, SMBC Capital, Sumitomo Mitsui Trust Investment, UTokyo Innovation Platform | Announced |
| Nov 22, 2019 | $25.8M Series B | — | Astellas Venture Management, Gene Techno Science, Jmdc, Nissay Capital, SBI Investment, SMBC Capital | Announced |
Heartseed has raised $76.6M in total across 3 funding rounds.
Heartseed's investors include Atsushi Sakano, Arcus South East Asia, Japan Co-Invest IV Limited Partnership, Keio Innovation Initiative, Koei Tecmo Capital, Medical Incubator Japan, Nikon-SBI Innovation Fund, Private Equity Co-Invest II Limited Partnership, SMBC Venture Capital, UTokyo Innovation Platform, Itochu Chemical Frontier, MEDIPAL HOLDINGS CORPORATION.